I join with my chorus of colleagues who come here advocating against an increase in interest rates in this country. But more importantly, I come today, to inform the House of a new scientific breakthrough that could mean relief for thousands of Americans. It was announced the day before yesterday that researchers at Johns Hopkins have found that the drug hydroxyurea can alleviate some of the painful symptoms associated with sickle cell anemia, such as incapacitating pain in the abdomen, joints, and back. Sickle cell anemia affects people whose ancestors come from Africa, the Middle East, the Mediterranean basin, and India. Sickle cell affects 1 in 12 African-Americans. African-American males suffering from this disease live an average of 42 years and African-American women live an average of 46 years. Although hydroxyurea, according to scientists, is not a cure for this deadly disease, it is an effective agent for improving the quality of life for those who suffer from sickle cell. I urge the FDA to quickly approve the use of hydroxyurea.
Editor's note · Context
Discussing a scientific breakthrough related to sickle cell anemia and advocating for FDA approval of hydroxyurea.
Share
More from Alcee Hastings
If it had not been for Section 5, G.K. Butterfield and Marcia Fudge and I would not be sitting here in the United States Congress.
Can anybody in here, particularly those of us on the Rules Committee, name any other President in the history of the United States that has asked a foreign government or its leaders to investigate an American citizen for political purposes?
We find ourselves here today discussing two Articles of Impeachment against President Donald John Trump because of his disregard of and disrespect for the United States Constitution.
As is clear, I and Bill Johnson are from south Florida, and I know that hurricanes ruin lives, displace people from their homes, their jobs, and their communities.





